Agios Pharmaceuticals (AGIO) Other Operating Expenses (2017 - 2026)

Agios Pharmaceuticals' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Other Operating Expenses rose 21.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 98.51% YoY) and the FY2024 annual result came in at $200.0 million, changed N/A from the prior year.
• Other Operating Expenses was $1.3 million for Q1 2026 at Agios Pharmaceuticals, down from $1.7 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $200.0 million in Q3 2024 and bottomed at -$9.9 million in Q4 2022.
• A 5-year average of $17.3 million and a median of $1.4 million in 2024 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 122.15% in 2022, while the deepest fall reached 473.29% in 2022.
• Agios Pharmaceuticals' Other Operating Expenses stood at -$9.9 million in 2022, then jumped by 111.25% to $1.1 million in 2023, then jumped by 17950.54% to $200.0 million in 2024, then tumbled by 99.15% to $1.7 million in 2025, then slipped by 22.5% to $1.3 million in 2026.
• Business Quant data shows AGIO's Other Operating Expenses at $1.3 million in Q1 2026, $1.7 million in Q2 2025, and $1.1 million in Q1 2025.